Pharmacokinetics of lansoprazole injection in peptic ulcer and healthy volunteers
The pharmacokinetics of lansoprazole after a single intravenous dose of 30 mg was determined in 10 healthy volunteers and 10 peptic ulcers patients. In this work, a liquid-liquid extraction and enrichment method with RP-HPLC determination route was taken with high sensitivity and low limit detection...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Articulo Comunicacion |
| Lenguaje: | Inglés |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/8253 http://www.latamjpharm.org/resumenes/30/5/LAJOP_30_5_2_6.pdf |
| Aporte de: |
| Sumario: | The pharmacokinetics of lansoprazole after a single intravenous dose of 30 mg was determined in 10 healthy volunteers and 10 peptic ulcers patients. In this work, a liquid-liquid extraction and enrichment method with RP-HPLC determination route was taken with high sensitivity and low limit detection of 5 ng/mL. The concentration-time curves in the two groups were best fitted to a two-compartment model, but their main kinetic parameters were remarkably different between healthy and ulcers volunteers. The mean maximum plasma concentration (C<sub>max</sub> ) and area under the curve (AUC<sub>0t</sub> ) were increased from 975.8 ng/mL to 1298.7 ng/mL and from 1439 ng·h/mL to 2301 ng·h/mL, respectively, and peak time (t<sub>max</sub> ) decreased from 0.36 h to 0.26 h. Meanwhile, the half life (t<sub>1/2</sub> ) prolonged from 2.25 h to 2.91 h and the clearance (CL) reduced from 20.04 L/h to 13.96 L/h. That variability of lansoprazole pharmakinetic parameter indicates that ulcers have significant effect on its metabolic process. |
|---|